542,10 € VAT excl.
Qualitative enzyme-linked immunosorbent assay of specific IgA antibodies against Covid-19 based on the ELISA technique. The 96-well ELISA plates are coated with the recombinant specific antigen (Mpro or also called 3CLpro) to bind the antibodies present in human serum and plasma samples (K2-EDTA, K3-EDTA, Heparin-Li, Sodium Citrate). The intended use of the assay is to assist in the identification of individuals with an adaptive immune response to SARS-CoV-2, indicating a previous or recent infection and contributing in combination with other tests (PCR or antigen), to the determination of the stage of infection. Additionally, this assay can be used in research, seroprevalence studies and epidemiological surveillance.
Regulatory Status | |
---|---|
Tested Applications | |
Size | |
Species Reactivity | |
Storage | Store in the dark at 2-8°C. |
Content kit | The reagents included in a kit are sufficient to carry out 96 determinations. Each anti-SARS-CoV-2 IgA ELISA kit contains:
|
Highly sensitive and specific test developed by Immunostep under CSIC patent licence, for the precise detection of IgA antibodies against the Mpro (3CLpro) Protein of SARS-Cov-2 virus.
Technical Data Sheet (TDS) (CE-IVD) – (English)
Safety Sheet (MSDS) (CE-IVD) – (English)
Product description | Reference | Title | Authors | Journal | Year | |
---|---|---|---|---|---|---|
Product description | Reference | Title | Authors | Journal | Year |
© 2024 Immunostep